S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Sell every Stock except ONE (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Most profitable less than $5 stock in the world? (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Sell every Stock except ONE (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Most profitable less than $5 stock in the world? (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Sell every Stock except ONE (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Most profitable less than $5 stock in the world? (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Sell every Stock except ONE (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Most profitable less than $5 stock in the world? (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)

DocuSign - DOCU Stock Forecast, Price & News

$74.32
+1.98 (+2.74%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$72.60
$77.24
50-Day Range
$56.81
$90.10
52-Week Range
$55.86
$314.76
Volume
3.53 million shs
Average Volume
2.95 million shs
Market Capitalization
$14.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$131.20

DocuSign MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
76.5% Upside
$131.20 Price Target
Short Interest
Healthy
8.35% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.15
Upright™ Environmental Score
News Sentiment
0.42mentions of DocuSign in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.48) to ($0.28) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.27 out of 5 stars

Business Services Sector

139th out of 431 stocks

Prepackaged Software Industry

101st out of 269 stocks

DOCU stock logo

About DocuSign (NASDAQ:DOCU) Stock

DocuSign, Inc. provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management. The company provides Guided Forms, which enable complex forms to be filled via an interactive and step-by-step process; Click that supports no-signature-required agreements for standard terms and consents; Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Payments that enables customers to collect signatures and payment; Remote Online Notary is a solution using audio-visual and identify verification technologies to enable notarization; and Monitor using advanced analytics to track DocuSign eSignature web, mobile, and API account. It offers industry-specific cloud offerings, including Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; Rooms for Mortgage, which offers digital workspace to create and close mortgages; FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise, commercial, and small businesses. The company was incorporated in 2003 and is headquartered in San Francisco, California.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Piper Sandler cut DocuSign from a "neutral" rating to an "underweight" rating and reduced their target price for the stock from $65.00 to $54.00 in a report on Wednesday, July 20th. UBS Group reduced their target price on DocuSign from $85.00 to $70.00 and set a "neutral" rating on the stock in a report on Friday, June 10th. Royal Bank of Canada reduced their target price on DocuSign from $85.00 to $80.00 in a report on Friday, June 10th. Wolfe Research cut DocuSign from a "market perform" rating to an "underperform" rating and set a $50.00 target price on the stock. in a report on Monday, June 13th. Finally, Morgan Stanley reduced their target price on DocuSign from $80.00 to $73.00 and set an "equal weight" rating on the stock in a report on Friday, June 10th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, DocuSign currently has a consensus rating of "Hold" and an average price target of $131.20.

DocuSign Trading Up 2.7 %

NASDAQ:DOCU opened at $74.32 on Tuesday. DocuSign has a fifty-two week low of $55.86 and a fifty-two week high of $314.76. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $14.86 billion, a PE ratio of -165.15 and a beta of 1.21. The business's 50-day simple moving average is $67.41 and its 200-day simple moving average is $87.60.

DocuSign (NASDAQ:DOCU - Get Rating) last announced its earnings results on Thursday, June 9th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.04). DocuSign had a negative net margin of 4.00% and a negative return on equity of 17.17%. The firm had revenue of $588.69 million during the quarter, compared to analyst estimates of $581.85 million. During the same period in the prior year, the business posted ($0.03) EPS. The firm's quarterly revenue was up 25.5% compared to the same quarter last year. Sell-side analysts expect that DocuSign will post -0.48 earnings per share for the current fiscal year.

Receive DOCU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocuSign and its competitors with MarketBeat's FREE daily newsletter.

DOCU Stock News Headlines

How Low Can DocuSign Stock Go?
Digital signature cloud company DocuSign (NASDAQ: DOCU) stock has fallen (-60%) and lost its CEO in this year’s bear market. The enterprise e-signature business took an unexpected jolt higher during the pandemic lockdowns
Why MongoDB, Twilio, and DocuSign Rallied on Monday
What Are Whales Doing With DocuSign
DocuSign Sees Unusually High Options Volume (NASDAQ:DOCU)
Why This DocuSign Analyst Says There's Downside Ahead
See More Headlines
Receive DOCU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocuSign and its competitors with MarketBeat's FREE daily newsletter.

DOCU Company Calendar

Last Earnings
6/09/2022
Today
8/08/2022
Next Earnings (Estimated)
9/01/2022
Fiscal Year End
1/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:DOCU
Fax
N/A
Employees
7,461
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$131.20
High Stock Price Forecast
$340.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+76.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
16 Analysts

Profitability

Net Income
$-69,980,000.00
Pretax Margin
-3.87%

Debt

Sales & Book Value

Annual Sales
$2.11 billion
Cash Flow
$0.99 per share
Book Value
$1.39 per share

Miscellaneous

Free Float
194,845,000
Market Cap
$14.86 billion
Optionable
Optionable
Beta
1.21

Key Executives














DOCU Stock - Frequently Asked Questions

Should I buy or sell DocuSign stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DocuSign in the last twelve months. There are currently 4 sell ratings, 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCU shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCU, but not buy additional shares or sell existing shares.
View DOCU analyst ratings
or view top-rated stocks.

What is DocuSign's stock price forecast for 2022?

16 analysts have issued 1-year target prices for DocuSign's stock. Their DOCU share price forecasts range from $50.00 to $340.00. On average, they predict the company's share price to reach $131.20 in the next year. This suggests a possible upside of 76.5% from the stock's current price.
View analysts price targets for DOCU
or view top-rated stocks among Wall Street analysts.

How has DocuSign's stock performed in 2022?

DocuSign's stock was trading at $152.31 at the start of the year. Since then, DOCU stock has decreased by 51.2% and is now trading at $74.32.
View the best growth stocks for 2022 here
.

When is DocuSign's next earnings date?

DocuSign is scheduled to release its next quarterly earnings announcement on Thursday, September 1st 2022.
View our DOCU earnings forecast
.

How were DocuSign's earnings last quarter?

DocuSign, Inc. (NASDAQ:DOCU) announced its earnings results on Thursday, June, 9th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.04. The business had revenue of $588.69 million for the quarter, compared to analyst estimates of $581.85 million. DocuSign had a negative net margin of 4.00% and a negative trailing twelve-month return on equity of 17.17%. The company's revenue for the quarter was up 25.5% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.03) EPS.

What guidance has DocuSign issued on next quarter's earnings?

DocuSign updated its second quarter 2023 earnings guidance on Thursday, July, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $600.00 million-$604.00 million, compared to the consensus revenue estimate of $601.71 million.

What is Daniel Springer's approval rating as DocuSign's CEO?

782 employees have rated DocuSign Chief Executive Officer Daniel Springer on Glassdoor.com. Daniel Springer has an approval rating of 98% among the company's employees. This puts Daniel Springer in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of DocuSign own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DocuSign investors own include NVIDIA (NVDA), Block (SQ), Tesla (TSLA), Advanced Micro Devices (AMD), Zoom Video Communications (ZM), PayPal (PYPL), Salesforce (CRM), Alibaba Group (BABA), Shopify (SHOP) and Netflix (NFLX).

When did DocuSign IPO?

(DOCU) raised $542 million in an IPO on Friday, April 27th 2018. The company issued 21,700,000 shares at $24.00-$26.00 per share. Morgan Stanley and J.P. Morgan acted as the underwriters for the IPO and Citigroup, BofA Merrill Lynch, Deutsche Bank Securities, JMP Securities, Pper Jaffray and William Blair were co-managers.

What is DocuSign's stock symbol?

DocuSign trades on the NASDAQ under the ticker symbol "DOCU."

Who are DocuSign's major shareholders?

DocuSign's stock is owned by a variety of institutional and retail investors. Top institutional investors include Liontrust Investment Partners LLP (0.90%), Sumitomo Mitsui Trust Holdings Inc. (0.30%), Walleye Trading LLC (0.00%), National Bank of Canada FI (0.22%), Scout Investments Inc. (0.19%) and TD Asset Management Inc. (0.14%). Insiders that own company stock include Cynthia Gaylor, Daniel D Springer, Enrique T Salem, Enrique T Salem, John M Hinshaw, Kirsten O Wolberg, Loren Alhadeff, Peter Solvik, Scott V Olrich and Tram T Phi.
View institutional ownership trends
.

How do I buy shares of DocuSign?

Shares of DOCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DocuSign's stock price today?

One share of DOCU stock can currently be purchased for approximately $74.32.

How much money does DocuSign make?

DocuSign (NASDAQ:DOCU) has a market capitalization of $14.86 billion and generates $2.11 billion in revenue each year. The company earns $-69,980,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

How many employees does DocuSign have?

DocuSign employs 7,461 workers across the globe.

How can I contact DocuSign?

DocuSign's mailing address is 221 Main St. Suite 1550, San Francisco CA, 94105. The official website for the company is www.docusign.com. The company can be reached via phone at (415) 489-4940 or via email at investors@docusign.com.

This page (NASDAQ:DOCU) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.